This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: National Institute of Health and Medical Research, The University of Nantes. Active years: 2018.
Company Filing History:
2 out of 1,853 
2 out of 156 
Years Active: 2018
Title: Elodie Picarda: Innovator in Transplant Tolerance
Introduction
Elodie Picarda is a notable inventor based in Nantes, France. She has made significant contributions to the field of immunology, particularly in the area of transplant tolerance. With a focus on developing innovative solutions to prevent transplant rejection, her work has garnered attention in the scientific community.
Latest Patents
Elodie Picarda holds 2 patents that reflect her groundbreaking research. One of her latest inventions is an isolated donor MHC-derived peptide that induces tolerance and prevents transplant rejection in patients. This invention involves a peptide derived from a polymorphic region of donor MHC class II molecules. The isolated peptide, which ranges between 11 and 16 amino acids, comprises the amino acid sequence: SDVGEYR or a function-conservative variant for use as a drug. Additionally, she has developed an in vitro method for determining whether a transplanted patient is tolerant, which includes assessing the presence of CD8+CD45RCTregs in a biological sample from the patient.
Another significant patent by Picarda also focuses on an isolated donor MHC-derived peptide. This invention includes a peptide of 15 or 16 amino acids that consists of the amino acid sequence: REEYARFDSDVGEYR or a function-conservative variant for use as a drug. Similar to her previous work, this invention also involves an in vitro method for determining transplant tolerance through the presence of CD8CD45RCTregs.
Career Highlights
Throughout her career, Elodie Picarda has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Université de Nantes. Her research has been pivotal in advancing the understanding of transplant immunology and developing therapeutic strategies.
Collaborations
Elodie has collaborated with notable colleagues, including Carole Guillonneau and Ignacio Anegon. These partnerships have contributed to her innovative research and the successful development of her patents.
Conclusion
Elodie Picarda is a distinguished inventor whose work in transplant tolerance has the potential to transform patient care. Her innovative patents and collaborations highlight her commitment to advancing medical science.